Global Neurodegenerative Diseases Market 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Neurodegenerative Diseases Market
2015-2019 Growth, Global Share, Industry
Overview, Analysis, Trends Opportunities and
Forecast
2
Description
Report Overview
About neurodegenerative diseases According to the
EU JPND, neurodegenerative diseases refer to
conditions that involve the neurons in the brain.
These conditions can affect balance, movement,
speech, and respiratory and cardiac functions.
They can be inherited or be of unknown etiology.
Neurodegenerative diseases are incurable and are
severely debilitating. They result in progressive
degeneration of nerve cells, causing them to die
eventually. These diseases cause ataxia and
dementia in people, which can have a serious
impact on the mental health of patients. Some
examples of neurodegenerative diseases are
Alzheimers disease, Parkinsons disease,
Huntingtons disease, multiple sclerosis,
amyotrophic lateral sclerosis, and epilepsy.
Huntingtons disease and amyotrophic lateral
sclerosis are rare diseases, unlike Alzheimers
disease and Parkinsons disease which have a high
degree of prevalence.   The global
neurodegenerative diseases market to grow at a
CAGR of 4.77 percent over the period 2014-2019.
  Read more details at http//www.bigmarketresea
rch.com/global-neurodegenerative-diseases-2015-201
9-market
3
Key Benefits
Summery
Covered in this report This report covers the
present scenario and the growth prospects of the
global neurodegenerative diseases market for the
period 2015-2019. To calculate the market size,
the report considers revenue generated from the
sales of various drugs used in the treatment of
neurodegenerative diseases. The market includes
data from the sales of various drugs used in the
treatment of Alzheimer's Disease Parkinson's
Disease Multiple Sclerosis Epilepsy
Huntington's Disease  The report also presents
the vendor landscape and a corresponding detailed
analysis of the top vendors in the global
neurodegenerative diseases market. The vendor
landscape section includes a market share
analysis of the major vendors along with the
performances of their product portfolios. In
addition, it discusses the major drivers that
influence the growth of the market. It also
outlines the challenges faced by vendors and the
market at large, as well as the key trends that
are emerging in the market.
4
Key Audiences
Key Regions Americas APAC EMEA
  Key vendors Biogen Idec Merck Serono
Novartis Pfizer Teva Pharmaceutical
Industries UCB  
5
Table Of Contents
Key Audiences
Other Prominent Vendors AB Science Abbvie
Acorda Therapeutics Actavis Active Biotech
Adamas Pharmaceuticals Akorn Archer
Pharmaceuticals Astellas Auspex
Pharmaceuticals Bayer Boehringer Ingelheim
Covis Desitin Arzneimittel Eisai
6
Table Of Contents
Market Trends
Market driver High unmet medical needs For a
full, detailed list, view our report   Market
Challenge Generic erosion For a full,
detailed list, view our report   Market trend
Reformulation of marketed drugs For a full,
detailed list, view our report
7
Table Of Contents
Market Trends
 Key Questions Answered in this Report What
will the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?   Enquire about report
http//www.bigmarketresearch.com/report-enquiry/22
2191
8
Get Full Information At http//www.bigmarketrese
arch.com/global-neurodegenerative-diseases-2015-20
19-market